Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic Approach to Candida Sepsis.

Pappas1, Rex

  • 1Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Boulevard, 229 Tinsley Harrison Tower, Birmingham, AL 35294-0006, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study of B Decays to Charmonium States: B-->eta(c)K and B --> chi(c0)K.

Physical review letters·2001
Same author

Gd(0001): A semi-infinite three-dimensional heisenberg ferromagnet with ordinary surface transition

Physical review letters·2000
Same author

Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study.

Cardiovascular radiation medicine·2000
Same author

A Pro --> Ala substitution in melittin affects self-association, membrane binding and pore-formation kinetics due to changes in structural and electrostatic properties

Biophysical chemistry·2000
Same author

Parasites reduce attractiveness and reproductive success in male grain beetles.

Animal behaviour·2000
Same author

Magnetic polaron in ferro- and antiferromagnetic semiconductors.

Physical review. B, Condensed matter·1996

Serious Candida infections are a growing hospital problem. While fluconazole and amphotericin B are similar for candidemia, understanding risk factors guides empiric antifungal therapy in critically ill patients.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Hospital Epidemiology

Background:

  • Serious infections caused by Candida species represent an increasing challenge in healthcare settings.
  • Culture-proven candidemia treatment in nonneutropenic patients shows fluconazole and conventional amphotericin B are generally equivalent.
  • Empiric antifungal therapy for critically ill, febrile, nonneutropenic intensive care unit patients is less understood.

Purpose of the Study:

  • To review current understanding of invasive candidiasis treatment and empiric therapy.
  • To guide rational therapeutic choices by identifying key risk factors for invasive candidiasis.
  • To discuss the evolving landscape of Candida species and antifungal resistance.

Main Methods:

  • Literature review of studies on candidemia and invasive candidiasis treatment.

Related Experiment Videos

  • Analysis of risk factors associated with invasive fungal infections.
  • Evaluation of current and emerging antifungal agents, including lipid formulations of amphotericin B.

    • Main Results:

    • Fluconazole and conventional amphotericin B demonstrate comparable efficacy for candidemia in nonneutropenic patients.
    • Risk factor identification is crucial for guiding empiric antifungal therapy in high-risk populations.
    • Lipid formulations of amphotericin B are valuable for patients with renal dysfunction.
    • Non-albicans Candida species are increasingly implicated in invasive candidiasis.

    Conclusions:

    • Rational selection of antifungal therapy requires understanding patient-specific risk factors and pathogen susceptibility.
    • Further research is needed to optimize empiric antifungal strategies, particularly in intensive care settings.
    • Adapting treatment approaches based on emerging Candida species and resistance patterns is essential for managing this nosocomial threat.